Offering GMP compliant cleanroom spaces, the company will assist life science and biopharma companies
Space and service provider Chrysalis has launched, offering GMP compliant cleanroom spaces to support life science and biopharma companies accelerate the development of therapies.
“Our model is particularly valuable for programs where retaining process control, protecting IP, and minimizing risk are crucial considerations,” said Chrysalis CEO Sarah Stevens.
Tailored cleanroom environments are available in as little as four weeks, offering flexibility for varying project needs.
“Our approach gives our customers flexibility to take only the space and services they need, when they need it,” said Stevens.
Chrysalis aims to meet the growing demand for agile manufacturing solutions, scaling quickly and adapting to different stages of project development, including early development and commercialisation.
